Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study

医学 羟基氯喹 强的松 内科学 狼疮性肾炎 队列 系统性红斑狼疮 比例危险模型 戒毒 疾病 胃肠病学 类风湿性关节炎 肾炎 药品 药理学 2019年冠状病毒病(COVID-19) 传染病(医学专业)
作者
Serena Fasano,Melania Alessia Coscia,Luciana Pierro,Francesco Ciccia
出处
期刊:Lupus [SAGE Publishing]
卷期号:30 (6): 991-997 被引量:24
标识
DOI:10.1177/09612033211002269
摘要

A progressive tapering until withdrawal of glucocorticoids (GC) is considered one of the main goals of Systemic Lupus Erythematosus (SLE) management. However, which patient may be a candidate for safe GC withdrawal has not been determined yet. This study aimed to evaluate the rate of low-dose GC withdrawal in SLE patients in remission and to identify predictors of flares.Eligible patients were SLE patients in prolonged clinical remission defined by a cSLEDAI = 0 for at least 2 years and on a stable SLE treatment (including daily 5 mg prednisone). Flares were defined by SELENA-SLEDAI Flare Index. Predictors of flares after GC withdrawal were analyzed by Cox regression.We selected 56 patients in whom a GC withdrawal was attempted. 98 patients were in the prednisone maintenance group. The proportion of patients experiencing a flare was not significantly lower in the maintenance group than in the withdrawal group (p = 0.81). However, among the withdrawal group, the rate of flares was significantly higher in serologically active clinically quiescent (SACQ) patients (p < 0,0001). At Cox regression analysis, duration of hydroxychloroquine (HCQ) therapy and ≥5 year remission at withdrawal were protective factors, while a SACQ disease and history of lupus nephritis increased the risk of disease flare.GC withdrawal is an achievable target in SLE and may be attempted in patients in complete remission.However, it might underline a caution in patients with SACQ disease who may be at greater risk forflare when GCare discontinued. HCQ therapy and durable remission can significantly reduce the risk.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
奥利奥扭不开怎么办完成签到,获得积分10
刚刚
情怀的应助被1024504036采纳,获得10
刚刚
科研通AI65的应助被1024504036采纳,获得10
刚刚
Owen的应助被1024504036采纳,获得10
刚刚
TheNeuron完成签到,获得积分10
刚刚
刚刚
眼睛大夏柳完成签到,获得积分10
1秒前
清i晨完成签到,获得积分10
2秒前
2秒前
3秒前
张伟的应助被sagitar采纳,获得50
3秒前
小二郎的应助被yyps采纳,获得10
3秒前
4秒前
4秒前
孤独白拍完成签到,获得积分10
4秒前
zworld完成签到 ,获得积分10
4秒前
4秒前
11完成签到,获得积分10
6秒前
孤独白拍发布了新的文献求助20
7秒前
李爱国的应助被科研通管家采纳,获得10
7秒前
SciGPT的应助被科研通管家采纳,获得10
8秒前
英姑的应助被科研通管家采纳,获得10
8秒前
Wenlia的应助被科研通管家采纳,获得10
8秒前
所所的应助被赖葡萄采纳,获得10
8秒前
再睡亿分钟完成签到,获得积分10
8秒前
Eric发布了新的文献求助10
8秒前
赘婿的应助被261176采纳,获得10
8秒前
Maestro_S的应助被科研通管家采纳,获得10
8秒前
aqqq的应助被科研通管家采纳,获得30
8秒前
SciGPT的应助被科研通管家采纳,获得10
8秒前
共享精神的应助被科研通管家采纳,获得10
9秒前
乐乐的应助被科研通管家采纳,获得10
9秒前
9秒前
qiao完成签到,获得积分10
9秒前
robin完成签到,获得积分10
9秒前
Mia完成签到,获得积分10
9秒前
1024504036完成签到,获得积分10
10秒前
10秒前
旷野发布了新的文献求助10
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552